General Information
Drug ID
DR00267
Drug Name
Indomethacin
Synonyms
Aconip; Aconip (TN); Amuno; Apo-Indomethacin; Arthrexin; Artracin; Artrinovo; Artrivia; Bonidin; Bonidon; Bonidon Gel; Catlep; Chibro-amuno; Chrono-indicid; Chrono-indocid; Confortid; DESMETHYL INDOMETHACIN; Dolcidium; Dolcidium PL;Flexin continus; Dolovin; Durametacin; Elmetacin; Hicin; I 7378; IMN; IN1454; Idomethine; Imbrilon; Inacid; Indacin; Indameth; Indmethacine; Indo-Lemmon; Indo-Spray; Indo-phlogont; Indo-rectolmin; Indo-tablinen; Indochron E-R (TN); Indocid; Indocid (TN); Indocid (pharmaceutical); Indocid Pda; Indocid Sr; Indocin; Indocin (TN); Indocin I.V; Indocin I.V.; Indocin Sr; Indocin-SR (TN); Indolar SR; Indomecol; Indomed; Indomee; Indomet 140; Indometacin; Indometacin (JP15/INN); Indometacina; Indometacina [INN-Spanish]; Indometacine; Indometacine [INN-French]; Indometacinum; Indometacinum [INN-Latin]; Indometacyna; Indometacyna [Polish]; Indomethacin & MAP-30; Indomethacin (USP); Indomethacin [USAN:BAN]; Indomethacin, Indochron E-R, Indocin-SR, Indocid, Indocin, Indomethacin; Indomethacine; Indomethacinum; Indomethancin; Indomethazine; Indomethegan; Indomethine; Indometicina; Indometicina [Spanish]; Indomo; Indomod; Indoptic; Indoptol; Indorektal; Indoxen; Inflazon; Infrocin; Inteban sp; Lausit; Liometacen; Metacen; Metartril; Methazine; Metindol; Mezolin; Miametan; Mikametan; Mobilan; Novo-Methacin; Novomethacin; Reumacide; Rhemacin LA; Rheumacin LA; Sadoreum; Tannex; Vonum
Drug Type
Small molecular drug
Indication Moderate to severe rheumatoid arthritis [ICD11: FA20] Approved [1]
Therapeutic Class
Antiinflammatory Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=3715"></iframe>
3D MOL 2D MOL
Formula
C19H16ClNO4
Canonical SMILES
CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
InChI
InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)
InChIKey
CGIGDMFJXJATDK-UHFFFAOYSA-N
CAS Number
CAS 53-86-1
Pharmaceutical Properties Molecular Weight 357.79 Topological Polar Surface Area 68.5
Heavy Atom Count 25 Rotatable Bond Count 4
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 4
XLogP
4.3
PubChem CID
3715
PubChem SID
10321568 , 10525985 , 11111328 , 11111329 , 11113361 , 11121750 , 11122230 , 11335446 , 11360685 , 11362903 , 11363813 , 11365465 , 11366375 , 11368027 , 11368937 , 11370997 , 11370998 , 11371496 , 11373534 , 11373628 , 11376189 , 11377099 , 11404374 , 11446060 , 11461657 , 11466300 , 11467420 , 11484715 , 11486099 , 11488786 , 11490284 , 11491833 , 11494733 , 3225554 , 5032 , 5208606 , 611045 , 612102 , 6435989 , 7847209 , 7888379 , 7979604 , 8027945 , 8027950 , 8027958 , 8149387 , 8152346 , 832223 , 841055 , 856012
ChEBI ID
ChEBI:49662
TTD Drug ID
D0R1RS
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Indomethacin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1. Br J Cancer. 2007 Oct 22;97(8):1077-83.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.